Core Scientific acquisition expected close Q4 2025
Company: CoreWeave
What the later record shows
Outcome not yet confirmed
The latest passage (2025-09-25 424B3) still describes the merger as pending, with closing in the future. No passage reports the deal closing, being terminated, or the stockholder vote result, so the outcome cannot be determined.
“We anticipate the transaction will close in the fourth quarter of 2025, subject to the satisfaction or waiver of the closing conditions specified in the merger agreement.”
2025-08-12 · CoreWeave 10-Q filed 2025-08-13 View cached copy (2026-08-31)Live source ↗
“CoreWeave estimates that it will issue approximately 39,685,636 shares of CoreWeave common stock at closing pursuant to the Merger Agreement”
2025-09-25 · CoreWeave 424B3 filed 2025-09-26 View cached copy (2026-08-31)Live source ↗
Checked October 11, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.
The claim, verbatim
The Core Scientific acquisition is expected to close in Q4 2025, subject to customary closing conditions including regulatory approval and Core Scientific stockholder approval.
Source (primary)
coreweave 8-K exhibit (dp231291_ex9901.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-10-11)Live source ↗
Quote: “The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions, including regulatory approval and approval by Core Scientific stockholders.”
How we checked this
Checked on October 15, 2026. The cited source supports every part of this claim.
The release gives the expected Q4 2025 close and lists regulatory and Core Scientific stockholder approval among the closing conditions.
Confirmed in the source:
- The acquisition is expected to close in the fourth quarter of 2025
- Closing is subject to customary closing conditions
- The conditions include regulatory approval
- The conditions include approval by Core Scientific stockholders
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1769628/000095010325008492/dp231291_ex9901.htm) in full (19,372 characters, retrieved October 11, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms coreweave 8-K exhibit (dp231291_ex9901.htm)
Quote: “The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions, including regulatory approval and approval by Core Scientific stockholders.”